Frequency of dyslipidemia in patients with lichen planus

Authors

  • zunaira King edward medical university
  • wajeeha
  • madiha

DOI:

https://doi.org/10.66344/jpad.31.4.2021.1717

Abstract

Background Lichen planus is a chronic T-cell-mediated inflammatory disorder, where inflammation produces lipid metabolism disturbances and is therefore linked to increase in cardiovascular (CV) risk due to dyslipidemia. Increased reactive oxygen species and lipid peroxides have also been implicated in its pathogenesis..   Objective To determine the frequency of dyslipidemia in patients with lichen planus.   Methods In this cross sectional study 96 clinically diagnosed cases of lichen planus were included. Presence or absence of dyslipidemia was decided by the recorded parameters i.e. fasting lipid profile.   Results Mean age of the patients was 37.07±11.22 year. There were 47 males (49.0%) and 49 females (51.0%). Dyslipidemia was recorded in 38 patients (39.6%). Stratification with regard to age, gender, BMI, duration of disease and history of treatment was carried out.   Conclusion Lichen planus was significantly associated with an increased risk of dyslipidemia.  

Downloads

Published

2022-03-29

How to Cite

1.
zunaira, wajeeha, madiha. Frequency of dyslipidemia in patients with lichen planus. J Pak Assoc Dermatol [Internet]. 2022Mar.29 [cited 2026May3];31(4):643-6. Available from: https://www.jpad.com.pk/index.php/jpad/article/view/1717

Issue

Vol. 31 No. 4 (2021): October - December

Section

Original Articles

License

Submission declaration

Authors retain the copyright to their work and grant the 'Journal of Pakistan Association of Dermatologists (JPAD)' the right of first publication under a Creative Commons Attribution 4.0 International (CC BY 4.0) license. This license allows others to share, adapt, and reuse the work for any purpose, including commercial use, as long as appropriate credit is given to the original authors and the journal.

By submitting a manuscript, authors confirm that the work has not been published previously (except as an abstract, lecture, or academic thesis), is not under review elsewhere, and has been approved by all authors and relevant authorities. Once accepted, the article will be openly accessible under the CC BY 4.0 license, ensuring wide dissemination and reuse with proper attribution.